Orbimed Advisors LLC Boston Scientific Corp Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,273,000 shares of BSX stock, worth $311 Million. This represents 6.46% of its overall portfolio holdings.

Number of Shares

3,273,000

Previous 3,273,000 -0.0%

Holding current value

$311 Million

Previous $252 Million 8.82%

% of portfolio

6.46%

Previous 6.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $1.95 Million - $2.32 Million	-33,800 Reduced 1.02%	3,273,000 $224 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $3.67 Million - $4 Million	-73,100 Reduced 2.16%	3,306,800 $175 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $20.4 Million - $22.4 Million	-410,100 Reduced 10.82%	3,379,900 $183 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $4.88 Million - $5.41 Million	-108,200 Reduced 2.78%	3,790,000 $190 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $17.3 Million - $51.7 Million	-471,300 Reduced 10.79%	3,898,200 $151 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $8.11 Million - $10.8 Million	-230,000 Reduced 5.0%	4,369,500 $163 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $39 Million - $43 Million	-952,800 Reduced 17.16%	4,599,500 $204 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $10.7 Million - $12.6 Million	-281,300 Reduced 4.82%	5,552,300 $236 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $44.8 Million - $49.9 Million	-1,087,000 Reduced 15.71%	5,833,600 $253 Million
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $14 Million - $15.8 Million	397,600 Added 6.1%	6,920,600 $267 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $55.5 Million - $70.3 Million	1,675,700 Added 34.57%	6,523,000 $235 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $4.46 Million - $7.88 Million	172,500 Added 3.69%	4,847,300 $158 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $22.5 Million - $26.9 Million	-593,900 Reduced 11.27%	4,674,800 $211 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $59.8 Million - $64.5 Million	-1,483,800 Reduced 21.97%	5,268,700 $214 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $33.6 Million - $41.4 Million	962,100 Added 16.62%	6,752,500 $290 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $65.8 Million - $81 Million	-2,073,595 Reduced 26.37%	5,790,400 $205 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $56.2 Million - $66.1 Million	-1,710,700 Reduced 17.87%	7,863,995 $303 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $21.6 Million - $27.6 Million	-803,100 Reduced 7.74%	9,574,695 $313 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $221,886 - $251,294	-8,805 Reduced 0.08%	10,377,795 $284 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $74.6 Million - $89.7 Million	-3,010,400 Reduced 22.47%	10,386,600 $257 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $352 Million - $391 Million	13,397,000	13,397,000 $391 Million

Others Institutions Holding BSX

# of Institutions

1,543

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $136B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Boston Scientific Corp Transaction History